10-K/A

OXIGENE, INC.

Company: Oncotelic Therapeutics, Inc.
Filed: April 29, 2010
Period of Report: December 31, 2009
Accession Number: 0000950123-10-039834

View Document ↗ View on SEC.gov ↗